Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 43, 2013 - Issue 5
710
Views
36
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Interspecies variation in the metabolism of zoniporide by aldehyde oxidase

, , &
Pages 399-408 | Received 14 Aug 2012, Accepted 03 Sep 2012, Published online: 10 Oct 2012
 

Abstract

1. Aldehyde oxidase (AO) is a cytosolic enzyme that contributes to the Phase I metabolism of xenobiotics in human and preclinical species.

2. Current studies explored in vitro metabolism of zoniporide in various animal species and humans using S9 fractions. The animal species included commonly used pharmacology and toxicology models and domestic animals such as the cat, cow or bull, pig and horse.

3. In addition, gender and strain differences in some species were also explored.

4. All animals except the dog and cat converted zoniporide to 2-oxozoniporide (M1).

5. Michael-Menten kinetic studies were conducted in species that turned over zoniporide to M1.

6. Marked differences in KM, Vmax and Clint were observed in the oxidation of zoniporide.

7. Although the KM and Vmax of zoniporide oxidation in male and female human S9 was similar, some gender difference was observed in animals especially, in Vmax.

8. The domestic animals also showed marked species differences in the AO activity and affinity toward zoniporide.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.